Document is current
Any future updates will be listed below
-
Authors
Riesco-Martinez, Maria C.
Modrego, Andrea
Espinosa-Olarte, Paula
La Salvia, Anna
Garcia-Carbonero, Rocio https://orcid.org/0000-0002-3342-397X
-
Funding
Funding for this research was provided by:
Fundación Científica Asociación Española Contra el Cáncer (CLSEN19003RIES)
- License Information
-
More Information
Article History
Accepted: 1 August 2022
First Online: 18 August 2022
Declarations
:
: Rocio Garcia-Carbonero has participated as an invited speaker or consultant for AAA, Advanz Pharma, Amgen, Bayer, HMP, Ipsen, Merck, Midatech, MSD, Novartis, Pierre Fabre, Roche, Servier. Rocio Garcia-Carbonero has also received financial support for investigator-initiated trials from BMS, MSD, Pfizer. Maria C. Riesco-Martinez has participated as invited speaker or consultant for AAA, Servier, Roche, Merck, and Bayer and received financial support for investigator-initiated trials from BMS and MSD. Andrea Modrego, Paula Espinosa-Olarte, and Anna La Salvia declare no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
